Original Query: ALL
Previous Study | Return to List | Next Study

Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00077532
Recruitment Status : Completed
First Posted : February 12, 2004
Last Update Posted : June 22, 2012
National Cancer Institute (NCI)
Information provided by:
National Institutes of Health Clinical Center (CC)

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : January 2007
  Study Completion Date : February 2008